HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reliant Links With Philips To Develop Laser Skin-Care Device For Home Use

This article was originally published in The Rose Sheet

Executive Summary

Reliant Technologies Inc., developer of Fraxel laser systems, has partnered with electronics giant Philips to develop laser skin-rejuvenation technology for use at home, taking a cue from some of the industry's biggest players that are making moves toward the aesthetic devices market

You may also be interested in...



Battle Of Anti-Acne Devices Heats Up; Prescription Claro Is First To Use IPL

The number of devices touted as supplements or outright replacements for traditional acne treatments - based on their fast results and relative lack of adverse side effects - is on the rise

Battle Of Anti-Acne Devices Heats Up; Prescription Claro Is First To Use IPL

The number of devices touted as supplements or outright replacements for traditional acne treatments - based on their fast results and relative lack of adverse side effects - is on the rise

Consumers Turning From Salons/Spas To Economical “Do It Yourself” Options

Consumers accustomed to professional beauty services increasingly are turning to do-it-yourself home-use solutions for comparable results at a significantly reduced cost

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015612

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel